Jump to content


Takeda, Feel-Good Story Of The Day: Lilly Lose Bid To Overturn $9 Billion Award For Hiding Cancer Risk

  • Please log in to reply
No replies to this topic

#1 FiveNotions



  • Active Members
  • PipPipPipPipPipPipPipPip
  • 3,686 posts
  • LocationUS, East Coast
  • why_joining:
    I want my life back!

Posted 16 September 2014 - 06:56 PM

Takeda, Lilly lose bid to overturn $9 billion award for hiding cancer risk

Worth the read ... $9 B less attorneys' fees, still leaves a lot of money to be divided between 2,900 plaintiffs :)

FTA: "(Reuters) - Takeda Pharmaceutical Co Ltd and Eli Lilly & Co lost a bid to overturn a combined $9 billion punitive damage award by a U.S. jury for hiding cancer risks associated with their Actos diabetes drug, according to a court ruling.

"Plaintiffs have pointed to sufficient evidence from which the jury could have concluded that the 'information' about bladder cancer contained in Actos labels did not adequately warn of the increased risk of cancer," U.S. District Judge Rebecca Doherty of the Western District of Louisiana said on Wednesday.

The development is a setback for Takeda but leaves open the possibility of a retrial or reduced verdict, for which Japan's top drugmaker made a separate appeal in April.

. . .

This is the first federal case to be tried in consolidated multidistrict litigation comprising more than 2,900 lawsuits. In all three previous Actos trials, Takeda has said, judgments were entered in its favor.

. . .

0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users